Advertisements
Advertisements
प्रश्न
How did an American Company, Eli Lilly use the knowledge of r-DNA technology to produce human insulin?
Advertisements
उत्तर
The structure of insulin consists of two short polypeptide chains chain A and chain B, linked together by disulphide bridges. In mammals, including human beings, insulin is synthesised as a pro-hormone, which contains an extra stretch called the C peptide, which is removed during maturation into insulin. The rDNA technique is used for assembling insulin into the mature form.
In 1983, Eli Lilly, an American company, prepared two DNA sequences corresponding to the A and B chains of human insulin and introduced them into the plasmids of E. coli to produce insulin chains. Chains A and B were produced separately, extracted and combined by creating disulphide bonds to form human insulin.
APPEARS IN
संबंधित प्रश्न
Explain enzyme – replacement therapy to treat adenosine deaminase deficiency. Mention two disadvantages of this procedure.
Why do children cured by enzyme-replacement therapy adenosine deaminase deficiency need periodic treatment?
Answer the following question.
Explain the various steps involved in the production of artificial insulin.
Describe the role of high temperature.
Describe the role of bacterium Thermus aquaticus in carrying the process of polymerase chain reaction.
Vaccines that use components of a pathogenic organism rather than the whole organism are called ____________.
ADA is an enzyme which is deficient in a genetic disorder SCID. What is the full form of ADA?
Can a disease be detected before its symptoms appear? Explain the principle involved.
What is a recombinant DNA vaccine? Give two examples.
When a foreign DNA is introduced into an organism, how is it maintained in the host and how is it transferred to the progeny of the organism?
